Form 4: Oscar Health CEO Mark Bertolini Reports Vesting of Restricted Stock Units
SEC Form 4 Filing
Mark Bertolini, CEO of Oscar Health, reports the vesting of restricted stock units resulting in the issuance of Class A Common Stock.
Summary
- On April 3, 2025, Mark Bertolini, the CEO of Oscar Health, reported the vesting of 955,556 restricted stock units.
- These units converted into 955,556 shares of Class A Common Stock.
- Following the transaction, Bertolini directly owns 2,866,666 shares of Class A Common Stock.
- The restricted stock units vest in three equal annual installments beginning on April 3, 2024, contingent upon continued employment or service.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies.
Stakeholder Impact
- The vesting of restricted stock units may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| March 29, 2023 | Date of Power of Attorney execution. |
| April 3, 2024 | First vesting date of restricted stock units. |
| April 3, 2025 | Date of transaction: Vesting of restricted stock units and issuance of Class A Common Stock. |
| April 7, 2025 | Date of Form 4 signature. |
Keywords
Form 4, Oscar Health, Mark Bertolini, Restricted Stock Units, Class A Common Stock, Vesting, Beneficial Ownership, SEC, Director, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.